DFFN - Diffusion Pharmaceuticals Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 4/8/2020
Current
12/31/20199/30/20196/30/20193/31/2019
Market Cap (intraday) 5
13.74M15.42M8.68M13.38M12.54M
Enterprise Value 3
-192.34k9.55M601.69k8.36M4.55M
Trailing P/E
N/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/A
Price/Book (mrq)
0.681.140.541.030.80
Enterprise Value/Revenue 3
N/AN/AN/AN/AN/A
Enterprise Value/EBITDA 6
0.02-3.26-0.20-3.23-1.57

Trading Information

Stock Price History

Beta (5Y Monthly) 0.75
52-Week Change 3-88.34%
S&P500 52-Week Change 3-4.04%
52 Week High 36.4900
52 Week Low 30.2100
50-Day Moving Average 30.3608
200-Day Moving Average 30.6641

Share Statistics

Avg Vol (3 month) 34.03M
Avg Vol (10 day) 320.2M
Shares Outstanding 534.6M
Float 32.75M
% Held by Insiders 10.26%
% Held by Institutions 115.08%
Shares Short (Mar 30, 2020) 424.68k
Short Ratio (Mar 30, 2020) 40.02
Short % of Float (Mar 30, 2020) 40.07%
Short % of Shares Outstanding (Mar 30, 2020) 40.07%
Shares Short (prior month Feb 27, 2020) 4212.74k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:15
Last Split Date 3Dec 13, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Dec 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-34.13%
Return on Equity (ttm)-66.02%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -11.45M
Net Income Avi to Common (ttm)-11.8M
Diluted EPS (ttm)-1.7590
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)14.18M
Total Cash Per Share (mrq)0.41
Total Debt (mrq)247.04k
Total Debt/Equity (mrq)1.23
Current Ratio (mrq)8.51
Book Value Per Share (mrq)0.60

Cash Flow Statement

Operating Cash Flow (ttm)-9.86M
Levered Free Cash Flow (ttm)-5.35M